1
|
Choi TH, Yoo RJ, Park JY, Kim JY, Ann YC, Park J, Kim JS, Kim K, Shin YJ, Lee YJ, Lee KC, Park J, Chung H, Seok SH, Im HJ, Lee YS. Development of finely tuned liposome nanoplatform for macrophage depletion. J Nanobiotechnology 2024; 22:83. [PMID: 38424578 PMCID: PMC10903058 DOI: 10.1186/s12951-024-02325-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Accepted: 01/30/2024] [Indexed: 03/02/2024] Open
Abstract
BACKGROUND Immunotherapy with clodronate-encapsulated liposomes, which induce macrophage depletion, has been studied extensively. However, previously reported liposomal formulation-based drugs (Clodrosome® and m-Clodrosome®) are limited by their inconsistent size and therapeutic efficacy. Thus, we aimed to achieve consistent therapeutic effects by effectively depleting macrophages with uniform-sized liposomes. RESULTS We developed four types of click chemistry-based liposome nanoplatforms that were uniformly sized and encapsulated with clodronate, for effective macrophage depletion, followed by conjugation with Man-N3 and radiolabeling. Functionalization with Man-N3 improves the specific targeting of M2 macrophages, and radioisotope labeling enables in vivo imaging of the liposome nanoplatforms. The functionalized liposome nanoplatforms are stable under physiological conditions. The difference in the biodistribution of the four liposome nanoplatforms in vivo were recorded using positron emission tomography imaging. Among the four platforms, the clodronate-encapsulated mannosylated liposome effectively depleted M2 macrophages in the normal liver and tumor microenvironment ex vivo compared to that by Clodrosome® and m-Clodrosome®. CONCLUSION The newly-developed liposome nanoplatform, with finely tuned size control, high in vivo stability, and excellent ex vivo M2 macrophage targeting and depletion effects, is a promising macrophage-depleting agent.
Collapse
Affiliation(s)
- Tae Hyeon Choi
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826, South Korea
| | - Ran Ji Yoo
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea
- Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, South Korea
- Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea
| | - Ji Yong Park
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea
- Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, South Korea
| | - Ji Yoon Kim
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea
- Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, South Korea
| | - Young Chan Ann
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea
- School of Dentistry, Seoul National University, Seoul, South Korea
| | - Jeongbin Park
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826, South Korea
| | - Jin Sil Kim
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea
| | - Kyuwan Kim
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea
| | - Yu Jin Shin
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
| | - Yong Jin Lee
- Division of Applied RI, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul, South Korea
| | - Kyo Chul Lee
- Division of Applied RI, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul, South Korea
| | - Jisu Park
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
- Department of Microbiology and Immunology, and Institute of Endemic Disease, Seoul National University College of Medicine, Seoul, South Korea
| | - Hyewon Chung
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
- Department of Microbiology and Immunology, and Institute of Endemic Disease, Seoul National University College of Medicine, Seoul, South Korea
| | - Seung Hyeok Seok
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
- Department of Microbiology and Immunology, and Institute of Endemic Disease, Seoul National University College of Medicine, Seoul, South Korea
| | - Hyung-Jun Im
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826, South Korea.
- Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, South Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
| | - Yun-Sang Lee
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, South Korea.
- Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, South Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.
| |
Collapse
|
2
|
Chung H, Park JY, Kim K, Yoo RJ, Suh M, Gu GJ, Kim JS, Choi TH, Byun JW, Ju YW, Han W, Ryu HS, Chung G, Hwang DW, Kim Y, Kang HR, Na YR, Choi H, Im HJ, Lee YS, Seok SH. Circulation Time-Optimized Albumin Nanoplatform for Quantitative Visualization of Lung Metastasis via Targeting of Macrophages. ACS Nano 2022; 16:12262-12275. [PMID: 35943956 PMCID: PMC9413422 DOI: 10.1021/acsnano.2c03075] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
The development of molecular imaging probes to identify key cellular changes within lung metastases may lead to noninvasive detection of metastatic lesions in the lung. In this study, we constructed a macrophage-targeted clickable albumin nanoplatform (CAN) decorated with mannose as the targeting ligand using a click reaction to maintain the intrinsic properties of albumin in vivo. We also modified the number of mannose molecules on the CAN and found that mannosylated serum albumin (MSA) harboring six molecules of mannose displayed favorable pharmacokinetics that allowed high-contrast imaging of the lung, rendering it suitable for in vivo visualization of lung metastases. Due to the optimized control of functionalization and surface modification, MSA enhanced blood circulation time and active/passive targeting abilities and was specifically incorporated by mannose receptor (CD206)-expressing macrophages in the metastatic lung. Moreover, extensive in vivo imaging studies using single-photon emission computed tomography (SPECT)/CT and positron emission tomography (PET) revealed that blood circulation of time-optimized MSA can be used to discern metastatic lesions, with a strong correlation between its signal and metastatic burden in the lung.
Collapse
Affiliation(s)
- Hyewon Chung
- Macrophage
Lab, Department of Microbiology and Immunology, and Institute of Endemic
Disease, Seoul National University College
of Medicine, Seoul 03080, Republic of Korea
- Bio-MAX
Institute, Seoul National University, Seoul 03080, Republic
of Korea
| | - Ji Yong Park
- Department
of Biomedical Sciences, Seoul National University
College of Medicine, Seoul 03080, Republic of Korea
- Department
of Nuclear Medicine, Seoul National University
Hospital, Seoul 03080, Republic of Korea
- Cancer
Research Institute, Seoul National University, Seoul 03080, Republic of Korea
- Dental
Research Institute, Seoul National University, Seoul 03080, Republic of Korea
| | - Kyuwan Kim
- Department
of Nuclear Medicine, Seoul National University
Hospital, Seoul 03080, Republic of Korea
- Cancer
Research Institute, Seoul National University, Seoul 03080, Republic of Korea
| | - Ran Ji Yoo
- Department
of Nuclear Medicine, Seoul National University
Hospital, Seoul 03080, Republic of Korea
- Cancer
Research Institute, Seoul National University, Seoul 03080, Republic of Korea
| | - Minseok Suh
- Department
of Molecular Medicine and Biopharmaceutical Sciences, Graduate School
of Convergence Science and Technology, Seoul
National University, Seoul 03080, Republic of Korea
| | - Gyo Jeong Gu
- Macrophage
Lab, Department of Microbiology and Immunology, and Institute of Endemic
Disease, Seoul National University College
of Medicine, Seoul 03080, Republic of Korea
| | - Jin Sil Kim
- Department
of Nuclear Medicine, Seoul National University
Hospital, Seoul 03080, Republic of Korea
| | - Tae Hyeon Choi
- Department
of Nuclear Medicine, Seoul National University
Hospital, Seoul 03080, Republic of Korea
- Department
of Molecular Medicine and Biopharmaceutical Sciences, Graduate School
of Convergence Science and Technology, Seoul
National University, Seoul 03080, Republic of Korea
| | - Jung Woo Byun
- Department
of Nuclear Medicine, Seoul National University
Hospital, Seoul 03080, Republic of Korea
| | - Young Wook Ju
- Department
of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic
of Korea
| | - Wonshik Han
- Department
of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic
of Korea
| | - Han Suk Ryu
- Department
of Pathology, Seoul National University
College of Medicine, Seoul 03080, Republic of Korea
| | - Gehoon Chung
- Dental
Research Institute, Seoul National University, Seoul 03080, Republic of Korea
- Department
of Oral Physiology, Seoul National University,
School of Dentistry, Seoul 03080, Republic of Korea
| | - Do Won Hwang
- Department
of Nuclear Medicine, Seoul National University
Hospital, Seoul 03080, Republic of Korea
- Research and Development Center, THERABEST,
Co. Ltd., Seoul 03080, Republic of Korea
| | - Yujin Kim
- Department
of Biomedical Sciences, Seoul National University
College of Medicine, Seoul 03080, Republic of Korea
| | - Hye-Ryun Kang
- Department
of Biomedical Sciences, Seoul National University
College of Medicine, Seoul 03080, Republic of Korea
| | - Yi Rang Na
- Transdisciplinary Department of Medicine
and Advanced Technology, Seoul National
University Hospital, Seoul 03080, Republic of Korea
| | - Hongyoon Choi
- Department
of Nuclear Medicine, Seoul National University
Hospital, Seoul 03080, Republic of Korea
| | - Hyung-Jun Im
- Department
of Molecular Medicine and Biopharmaceutical Sciences, Graduate School
of Convergence Science and Technology, Seoul
National University, Seoul 03080, Republic of Korea
- Research Institute for Convergence Science, Seoul National University, Seoul 08823, Republic of Korea
| | - Yun-Sang Lee
- Department
of Biomedical Sciences, Seoul National University
College of Medicine, Seoul 03080, Republic of Korea
- Department
of Nuclear Medicine, Seoul National University
Hospital, Seoul 03080, Republic of Korea
- Cancer
Research Institute, Seoul National University, Seoul 03080, Republic of Korea
| | - Seung Hyeok Seok
- Macrophage
Lab, Department of Microbiology and Immunology, and Institute of Endemic
Disease, Seoul National University College
of Medicine, Seoul 03080, Republic of Korea
- Department
of Biomedical Sciences, Seoul National University
College of Medicine, Seoul 03080, Republic of Korea
| |
Collapse
|
3
|
Park JY, Lee YS, Yoo RJ, Choi TH, Kim J, Yang SH. Glucose-albumin nanoplatform for treating renal ischemia-reperfusion injury using reactive oxygen species scavenging properties. Nucl Med Biol 2022. [DOI: 10.1016/s0969-8051(22)00346-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Yoo RJ, Choi TH, Kim J, Kim YJ, Lee YS. Comparison of biodistribution according to administration route for the development of liposome therapeutics. Nucl Med Biol 2022. [DOI: 10.1016/s0969-8051(22)00349-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
5
|
Kim H, Shin E, Lee J, Yoo RJ, Park JW, Chung HK, Shim JH. Efficacy and imaging evaluation of 177Lu-labeled antibody-drug conjugates as a potential theranostic agent for HER2-positive breast cancer. Nucl Med Biol 2021. [DOI: 10.1016/s0969-8051(21)00441-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
6
|
Kim JK, Park S, Yoo RJ, Jeong HJ, Oh J, Lee YJ, Park S, Kim DW. Thin PEGylated Carbon Nitrides: Water-Dispersible Organic Nanodots as Bioimaging Probes. Chemistry 2018; 24:3506-3511. [DOI: 10.1002/chem.201704761] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2017] [Indexed: 01/18/2023]
Affiliation(s)
- Jin Kwan Kim
- Department of Chemistry and Chemical Engineering; Inha University; 100 Inha-ro, Nam-gu Incheon 22212 Korea
| | - Sunghee Park
- Department of Chemistry and Chemical Engineering; Inha University; 100 Inha-ro, Nam-gu Incheon 22212 Korea
- WCSL (World Class Smart Lab) Green Energy Battery Lab; Inha University; 100 Inha-ro, Nam-gu Incheon 22212 Korea
| | - Ran Ji Yoo
- Department Molecular Imaging Research Center; Korea Institute of Radiological and Medical Sciences; 75 Nowon-ro, Nowon-gu Seoul 139-706 Korea
| | - Hyeon Jin Jeong
- Department of Chemistry and Chemical Engineering; Inha University; 100 Inha-ro, Nam-gu Incheon 22212 Korea
| | - Junghoon Oh
- Department of Chemistry and Chemical Engineering; Inha University; 100 Inha-ro, Nam-gu Incheon 22212 Korea
- WCSL (World Class Smart Lab) Green Energy Battery Lab; Inha University; 100 Inha-ro, Nam-gu Incheon 22212 Korea
| | - Yong Jin Lee
- Department Molecular Imaging Research Center; Korea Institute of Radiological and Medical Sciences; 75 Nowon-ro, Nowon-gu Seoul 139-706 Korea
| | - Sungjin Park
- Department of Chemistry and Chemical Engineering; Inha University; 100 Inha-ro, Nam-gu Incheon 22212 Korea
- WCSL (World Class Smart Lab) Green Energy Battery Lab; Inha University; 100 Inha-ro, Nam-gu Incheon 22212 Korea
| | - Dong Wook Kim
- Department of Chemistry and Chemical Engineering; Inha University; 100 Inha-ro, Nam-gu Incheon 22212 Korea
| |
Collapse
|
7
|
Yoo RJ, Kim MH, Woo SK, Kim KI, Lee TS, Choi YK, Kang JH, Lim SM, Lee YJ. Monitoring of macrophage accumulation in statin-treated atherosclerotic mouse model using sodium iodide symporter imaging system. Nucl Med Biol 2017; 48:45-51. [PMID: 28208058 DOI: 10.1016/j.nucmedbio.2017.01.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2016] [Revised: 01/16/2017] [Accepted: 01/20/2017] [Indexed: 11/17/2022]
Abstract
INTRODUCTION Macrophages play a key role in atherosclerotic plaque formation in atherosclerosis, but its detailed understanding has poorly investigated until now. Thus, we sought to demonstrate a noninvasive technique for macrophage tracking to atherosclerotic lesions in apolipoprotein E-/-(ApoE-/-) mice with an imaging system based on sodium iodide symporter (NIS) gene coupled with 99mTc-single-photon emission computed tomography (SPECT). METHODS AND RESULTS Macrophage cells (RAW264.7) were stably transduced with retrovirus expressing NIS gene (RAW-NIS). In RAW-NIS cells, uptake of 125I was higher than the parental cells. [18F]FDG signals in the aorta at 30weeks on an ApoE-/- mice with high cholesterol diet were higher (1.7±0.12% injected dose (ID)) than those in control group (0.84±0.06% ID). Through 99mTc-SPECT/computed tomography (CT), in the RAW-NIS cell injected group, the 99mTc-pertechnetate uptake in aorta was higher than control groups. However, according to atorvastatin treatment, RAW-NIS cell recruitment reduced to the aorta. Area of 99mTc-pertechnetate uptake was positively correlated with immunostaining results against macrophage antigen (CD68). Cholesterol and low-density lipoprotein levels of atorvastatin-treated group showed lower than those of atorvastatin-untreated group, but did not reach statistical difference. CONCLUSIONS This novel approach to tracking macrophages to atherosclerotic plaques in vivo can be applied for studies of arterosclerotic vascular disease.
Collapse
Affiliation(s)
- Ran Ji Yoo
- Division of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea; Department of Laboratory Animal Medicine, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea
| | - Min Hwan Kim
- Division of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
| | - Sang-Keun Woo
- Division of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
| | - Kwang Il Kim
- Division of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
| | - Tae Sup Lee
- Division of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
| | - Yang-Kyu Choi
- Department of Laboratory Animal Medicine, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea
| | - Joo Hyun Kang
- Division of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
| | - Sang Moo Lim
- Department of Nuclear Medicine, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
| | - Yong Jin Lee
- Division of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
| |
Collapse
|
8
|
Park JA, Lee YJ, Lee JW, Yoo RJ, Shin UC, Lee KC, Kim BI, Kim KM, Kim JY. Evaluation of [(89)Zr]-Oxalate as a PET Tracer in Inflammation, Tumor, and Rheumatoid Arthritis Models. Mol Pharm 2016; 13:2571-7. [PMID: 27243098 DOI: 10.1021/acs.molpharmaceut.6b00411] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
To obtain an additional pharmacological agent for the diagnosis of inflammation, we investigated the medical use of (89)Zr-oxalate as a positron emission tomography (PET) probe for the in vivo imaging of inflammation and compared its efficacy to that of 2-deoxy-2-[(18)F]fluoro-d-glucose ([(18)F]FDG) and sodium [(18)F]fluoride. (89)Zr-oxalate exhibited observable higher uptake in a macrophage cell line than in tumor cells. The inflammatory lesions and tumors were clearly visualized by PET imaging and autoradiography using (89)Zr-oxalate. Compared to [(18)F]FDG and sodium [(18)F]fluoride, (89)Zr-oxalate demonstrated a high selectivity index to the tumor at an early time point after injection and to inflammation at a delayed time point after injection (24 h). Through histological examination, large numbers of macrophages and neutrophils were observed in the tumor lesions with the highest (89)Zr-oxalate uptake. In a rheumatoid arthritis (RA) mouse model, (89)Zr-oxalate demonstrated a high level of accumulation in inflammatory lesions. (89)Zr-oxalate is a new strategic tool for tumor imaging and inflammatory processes.
Collapse
Affiliation(s)
- Ji-Ae Park
- Molecular Imaging Research Center, Korea Institute of Radiological & Medical Science , Seoul 139-706, Republic of Korea
| | - Yong Jin Lee
- Molecular Imaging Research Center, Korea Institute of Radiological & Medical Science , Seoul 139-706, Republic of Korea
| | - Ji Woong Lee
- Molecular Imaging Research Center, Korea Institute of Radiological & Medical Science , Seoul 139-706, Republic of Korea
| | - Ran Ji Yoo
- Molecular Imaging Research Center, Korea Institute of Radiological & Medical Science , Seoul 139-706, Republic of Korea
| | - Un Chol Shin
- Molecular Imaging Research Center, Korea Institute of Radiological & Medical Science , Seoul 139-706, Republic of Korea
| | - Kyo Chul Lee
- Molecular Imaging Research Center, Korea Institute of Radiological & Medical Science , Seoul 139-706, Republic of Korea
| | - Byung Il Kim
- Department of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences , Seoul 139-706, Republic of Korea
| | - Kyeong Min Kim
- Molecular Imaging Research Center, Korea Institute of Radiological & Medical Science , Seoul 139-706, Republic of Korea
| | - Jung Young Kim
- Molecular Imaging Research Center, Korea Institute of Radiological & Medical Science , Seoul 139-706, Republic of Korea
| |
Collapse
|
9
|
Choi SH, Hong ZY, Nam JK, Lee HJ, Jang J, Yoo RJ, Lee YJ, Lee CY, Kim KH, Park S, Ji YH, Lee YS, Cho J, Lee YJ. A Hypoxia-Induced Vascular Endothelial-to-Mesenchymal Transition in Development of Radiation-Induced Pulmonary Fibrosis. Clin Cancer Res 2015; 21:3716-26. [DOI: 10.1158/1078-0432.ccr-14-3193] [Citation(s) in RCA: 99] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2014] [Accepted: 04/06/2015] [Indexed: 11/16/2022]
|
10
|
Oh J, Yoo RJ, Kim SY, Lee YJ, Kim DW, Park S. Oxidized Carbon Nitrides: Water-Dispersible, Atomically Thin Carbon Nitride-Based Nanodots and Their Performances as Bioimaging Probes. Chemistry 2015; 21:6241-6. [DOI: 10.1002/chem.201406151] [Citation(s) in RCA: 76] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2014] [Indexed: 12/23/2022]
|